Single answer
Is Aspire Biopharma Holdings Inc (ASBP) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Aspire Biopharma Holdings Inc an earlystage biopharmaceutical company develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States It offers Instaprin a sublingual aspirin product that is a soluble PH neutral and fast acting aspirin which addresses cardiology emergencies and pain management The company is also developing formulations for sublingually administered products including a melatonin sleepaid product vitamins D E and K testosterone and semaglutide product In addition it is developing formulations for antinausea products antipsychotic products ED drugs seizure medication and other classes of drugs through sublingual administration and caffeine products such as a formula for a single dose sublingual preworkout supplement The company was founded in 2021 and is headquartered in Estero Florida
Website: https://aspirebiolabs.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.58. Cash flow to debt ratio: -1.04. Net profit margin: -1,478,810.00%. Inflation risk score: high (1.00/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Aspire Biopharma Holdings Inc is $6.3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Aspire Biopharma Holdings Inc 10 years ago, but if you had invested on 2025-01-24 when the price was $12.11, you would have made a loss of $10.68 per share or 88.19%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.